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Abstract
Background: Consumption of oily fish or fish oil during pregnancy, lactation and
infancy has been linked to a reduction in the development of allergic diseases in
childhood.
Methods: In an observational study, Icelandic children (n = 1304) were prospectively
followed from birth to 2.5 years with detailed questionnaires administered at birth
and at 1 and 2 years of age, including questions about fish oil supplementation. Chil-
dren with suspected food allergy were invited for physical examinations, allergic sen-
sitization tests, and a double-blind, placebo-controlled food challenge if the allergy
testing or clinical history indicated food allergy. The study investigated the develop-
ment of sensitization to food and confirmed food allergy according to age and fre-
quency of postnatal fish oil supplementation using proportional hazards modelling.
Results: The incidence of diagnosed food sensitization was significantly lower in chil-
dren who received regular fish oil supplementation (relative risk: 0.51, 95% confi-
dence interval: 0.32-0.82). The incidence of challenge-confirmed food allergy was
also reduced, although not statistically significant (0.57, 0.30-1.12). Children who
began to receive fish oil in their first half year of life were significantly more protected
than those who began later (P = .045 for sensitization, P = .018 for allergy). Indicators
of allergy severity decreased with increased fish oil consumption (P = .013). Adjusting
for parent education and allergic family history did not change the results.
Conclusion: Postnatal fish oil consumption is associated with decreased food sensi-
tization and food allergies in infants and may provide an intervention strategy for
allergy prevention.
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1 | INTRODUCTION
Dietary changes have been suggested as an important factor for
increasing prevalence of food allergy. Of special interest is the
declining intake of omega-3 polyunsaturated fatty acids (n-3 PUFA)
Abbreviations: CI, confidence interval; DBPCFC, double-blind, placebo-controlled food
challenge; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; IgE, immunoglobulin E;
LUH, Landspitali University Hospital; PUFA, polyunsaturated fatty acids; RR, relative risk;
SPT, skin prick test; Th1, T helper cell 1.
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with the concurrent rise in omega-6 polyunsaturated fatty acids (n-6
PUFA) and vitamin D deficiency.1,2 n-3 PUFA have an anti-inflamma-
tory effect by influencing the cell membrane structure, cell signalling
and antigen presentation.3,4 Diets rich in the n-3 PUFA eicosapen-
taenoic acid (EPA) and docosahexaenoic acid (DHA) have been
shown to decrease allergic symptoms in food-allergic mice. DHA-rich
diet also protected against allergic sensitization, indicating both pri-
mary and secondary prevention.5
Several studies have indicated a favourable allergic outcome in
infants related to maternal n-3 PUFA consumption during pregnancy,
although there have been inconsistent results between studies.6
The Childhood Asthma Prevention Study in Australia showed
that infants who received fish oil supplementation from birth had
increased n-3 PUFA levels in association with a decreased allergen-
specific T helper cell 2 (Th2) response and elevated polyclonal Th1
response, indicating that n-3 PUFA have immunomodulatory effects
during a critical time of immune vulnerability in early infant life.7 The
improved infant n-3 PUFA status did not prevent childhood allergic
disease.8,9
Low vitamin D status has been reported in concordance with an
increase in allergic diseases in infancy. Vitamin D modulates the
action of immune cells, such as T and B cells, monocytes and den-
dritic cells, and may, therefore, influence the development of allergic
diseases, including food allergy.10,11 Studies have shown conflicting
results regarding the association between vitamin D and the devel-
opment of food allergy, but recent studies have suggested a rather
protective role.1,12,13
To examine whether cod fish oil supplementation, which is rich
in n-3 PUFA and vitamins A and D, has an effect on food allergy
development, we evaluated the Icelandic birth cohort taking part in
the EuroPrevall birth cohort study on food allergies using a ques-
tionnaire database as well as information on sensitization and con-
firmed food allergy. Results published so far from the EuroPrevall
birth cohort show that, compared with the other participating Euro-
pean countries, Iceland is relatively high in food allergy
prevalence.14-16
2 | METHODS
2.1 | Study design and setting
This study is a longitudinal observational study without intervention.
The Icelandic directorate of health recommends that infants be given
vitamin D, 10 lg daily, from age 2 weeks until 6 months when it is
recommended to begin supplementing daily 5 mL dose of fish oil.
However, many parents in our cohort were not compliant with these
recommendations, which provided an opportunity to investigate the
relationship between vitamin D and fish oil supplementation and
food allergy in Icelandic infants.
The analysis was performed using data collected from the Euro-
Prevall birth cohort study in Iceland conducted within the collabora-
tive research initiative EuroPrevall. The methodology of the birth
cohort has previously been described in detail.17 Participation was
offered to parents of children born in Iceland from 2005 to mid-
2008. Participating children were followed from birth to 2.5 years of
age. Data for 1341 children were collected after birth and included
birth data, family history of allergies in parents and siblings, socio-
demographic status and environmental exposures.
Parents were asked to call to report any symptoms in their chil-
dren that were suggestive of food allergy. They underwent a stan-
dardized interview by a study nurse and, if needed, by a paediatric
allergist, and a decision was made regarding whether to bring the
child to the Landspitali University Hospital (LUH) in Reykjavik for
interviewing and examination. In addition, parents answered ques-
tionnaires over the phone at approximately 12 and 24 months. Data
were collected on breastfeeding, complementary intake and food
intake of the child and symptoms of allergies. When allergy was sus-
pected, a decision was again made on whether to bring the child to
the hospital.
The children who were brought to LUH underwent a physical
examination, skin prick testing (SPT) and a blood draw for food-spe-
cific immunoglobulin E (IgE) measurements, and when allergy was
suspected, a double-blind, placebo-controlled food challenge
(DBPCFC) was offered. The DBPCFC diagnosis was based on imme-
diate symptoms or delayed symptoms reported by parents within
24 hours (Appendix S1).
2.2 | Data and subjects for this study
The participants in this study were the children who completed a 12-
month questionnaire. The primary data used were the questionnaire
responses regarding complementary feeding of fish oil and vitamin D
during infancy, family history of allergy and demographic factors as well
as the results of the hospital allergy examination. In this study, the term
regular for both fish oil and vitamin D intake was used to represent
administration at least four times per week. Fish oil supplementation is
common in Iceland, and it is officially recommended that children should
be given fish oil from 6 months of age. The fish oil is primarily from cod
and is rich in n-3 PUFA and vitamins A and D (Table S1). Vitamin D sup-
plementation is recommended from age 2 weeks.18
To allow testing for confounding by family allergy history, a fam-
ily allergy index was computed, measuring the frequency and severity
of allergic diseases in first-degree relatives (Appendix S2). In addition,
to allow for quantitative analysis, a sensitization and allergy severity
index for the children was computed by combining the results of the
IgE measurements, SPT and DBPCFC (Appendix S3).
2.3 | Statistics
Matlab (version 2017a; MathWorks Inc.), including its Statistics tool-
box, was used to perform the statistical analyses. For the demographic
characteristics in the previous subsection, P-values for fractions were
computed using the chi-square test, and P-values for means were
computed using one-way analysis of variance. Fisher’s exact test was
used for the P-values in the preliminary calculation subsection below.
For detailed analysis, a proportional hazards model was built to
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estimate the protective effect of giving infants fish oil during their first
2 years, incorporating vitamin D supplementation, the family allergy
index and various other potentially confounding factors. The model
estimated relative risk (RR); a likelihood ratio was used to compute P-
values; and confidence intervals (CIs) were obtained with profile likeli-
hood. For quantitative analysis of the relationship between fish oil use
and allergy severity, a linear regression model of food allergy severity
on the frequency of fish oil use was constructed, with the t test used
to determine the P-value (Appendix S4).
2.4 | Ethics
The study was approved by The National Bioethics Committee in
Iceland (2005; VSNb2005070004) and the Icelandic Data Protection
Agency (2005/421). Written informed consent was obtained from all
parents prior to the participation of their children in the study.
3 | RESULTS
Of the 1341 children for whom birth data were collected, the 12-
month questionnaire was completed for 1304 children, resulting in
the participation of 636 girls and 668 boys in this study. The
24-month questionnaire was completed for 1244 children. A total of
515 parents called and were interviewed by a study nurse and, sub-
sequently, by a study physician, that is paediatric allergist, if food
allergy was suspected. A total of 249 children were seen at LUH for
further investigation.
3.1 | Primary findings
The primary result of the study was that regular fish oil use signifi-
cantly reduced the incidence of food sensitization (RR = 0.51, 95%
CI: 0.32-0.82, P = .006) in Icelandic infants irrespective of their fam-
ily history of allergy and other investigated confounding factors. Inci-
dence of sensitization and confirmed food allergy were significantly
lower in children who began early on regular fish oil (P = .045 and
.018, respectively, Table 1).
3.2 | Demographic factors, fish oil use and
vitamin D
Almost half of the study group was given fish oil regularly from the
age of 6 months or younger, and a further third began regular fish
oil intake at 7-15 months old. Table 2 summarizes the main demo-
graphic characteristics of the 1304 participating children according
to the age at which regular fish oil intake began. There were 787
children who were given vitamin D regularly, prior to fish oil use,
beginning at 0-2 months old and 517 who either received it less
often or started later. There were three variables that were signifi-
cantly related to fish oil use: presence of animals at home, adminis-
tration of infant formula with cow’s milk during the first week and
fish oil intake during pregnancy. These variables received special
TABLE 1 Food sensitization and food allergy between 9.5 and







Begin regular fish oil
3-6 mo old
596 16 (2.7%) 5 (0.8%)
Begin regular fish oil
7-9 mo old
281 9 (3.2%) 4 (1.4%)
No regular fish oil
before 15 mo




The table shows the cumulative incidence of sensitization among the
children who were not sensitized at 9.5 mo according to whether they
began regular fish oil when 3-6 mo old, when 7-9 mo old or whether
they did not receive regular fish oil supplementation before 15 mo. The
last column shows the incidence of confirmed food allergy among the
same children.









oil before 15 mo P
Size of group (fraction of total) 1304 (100.0%) 599 (45.9%) 434 (33.3%) 271 (20.8%)
Girls (fraction of group) 636 (49%) 299 (50%) 201 (46%) 136 (50%) .664
No 0- to 7-y-old siblings at home 724 (56%) 343 (57%) 230 (53%) 151 (56%) .602
High parent education 718 (55%) 333 (56%) 238 (55%) 147 (54%) .985
Animals at home 290 (22%) 154 (26%) 75 (17%) 61 (23%) .016
Regular fish oil during pregnancy 710 (54%) 368 (61%) 219 (50%) 123 (45%) <.001
Regular vit. D supplem. starting before 3 mo 787 (60%) 372 (62%) 262 (60%) 153 (56%) .478
Infant formula with cow milk during 1st week 387 (30%) 199 (33%) 117 (27%) 71 (26%) .082
Daily smoking during pregnancy 104 (8%) 48 (8%) 34 (8%) 22 (8%) .999
Family allergy severity index 2.1  2.0 2.1  1.9 2.1  2.2 2.2  1.8 .666
Mother’s age in years 30.1  4.8 30.0  4.8 30.1  4.8 30.2  4.8 .843
The last two lines show mean  standard deviation.
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attention in the modelling described below, and none of them were
found to have a confounding effect on the primary results.
Children with a family history of allergy did not receive signifi-
cantly more or less fish oil than other children. Of the 635 children
with a family allergy index above the median, 297 (47%) began regu-
lar fish oil supplementation at 1-6 months old, and an additional 204
(32%) began supplementation at 7-15 months old. Of the other 639
children who had a low family allergy index, 304 (48%) began regular
fish oil intake at 1-6 month old and another 244 (38%) began at 7-
15 months old. The family allergy index was also incorporated in the
modelling phase and did not alter the results.
3.3 | Diagnosed food sensitization and allergy
As stated above, 249 children were seen at LUH after food allergy
was suspected. Of these children, 85 (6.5% of the 1304) were diag-
nosed as sensitized to food based on positive SPT and/or IgE out-
comes. For 43 (3.3%) of the 85 children, the diagnosis was
confirmed as food allergy with DBPCFC. In 6, 1 and 2 cases, the
children were allergic to 2 foods, 3 foods and 4 foods, respectively.
The most common food allergens were hen’s eggs and cow’s milk,
followed by fish and peanuts (Table 3).
3.4 | Fish oil and food allergy—preliminary
calculation
There were 595 children, not allergic at 6 months, who received reg-
ular fish oil from that age or earlier. Of these, 24 (4.0%) were subse-
quently diagnosed with food sensitization and 11 (2.0%) with
confirmed food allergy. This contrasts with the 241 children who
never received regular fish oil. Of these, 27 (11.2%) were diagnosed
with food sensitization and 20 (7.9%) with food allergy after age
6 months (P < .001 for both sensitization and confirmed allergy).
Similar computation for vitamin D only, and for vitamin D and fish
oil combined, showed marginal but nonsignificant protection of vita-
min D (Table S2).
3.5 | Modelling the relationship between fish oil
use and food allergy
The calculation in the previous subsection did not consider the
464 children who began regular fish oil intake after 6 months of
age, but they were included in the more detailed analysis illus-
trated in Figure 1, which also provides a breakdown by age at
TABLE 3 Positive outcomes of sensitization/food challenge tests
in 249 Icelandic EuroPrevall birth cohort children, up to 2.5 y of age
Food
Number of tests with a positive outcome
SPT IgE/RAST DBPCFC
Eggs 51 46 28
Milk 30 46 13
Peanuts 14 19 6
Fish 10 9 8







Total 119 158 57
Total children 69 71 43
SPT, skin prick test, DBPCFC: double-blind placebo-controlled food chal-
lenge. IgE/RAST: serum IgE >0.35 kUA/L.
F IGURE 1 Monthly incidence of food sensitization and allergy according to age and fish oil use. The upper part of each bar (lighter colour)
shows the incidence of sensitization, diagnosed during the indicated age span, that is not accompanied by a positive double-blind placebo-
controlled food challenge (DBPCFC) outcome, and the lower part (darker colour) shows the incidence of sensitization followed by a positive
DBPCFC outcome. The numbers above the bars indicate the size of each reference group. On average, regular fish oil intake lowered the
incidence of sensitization by a factor of 2.0 (P = .006) and DBPCFC-confirmed allergy by a factor of 1.7 (nonsignificant, P = .095). See
Figure S1 for details
1308 | CLAUSEN ET AL.
diagnosis. The analysis is explained in more detail in Figure S1;
however, briefly, the incidence of sensitization (allergy) among
those who had begun regular fish oil intake was compared
with the incidence among those who had not. For the analysis,
the exact timing of the shift, that is from not getting fish oil to
getting regular fish oil, was considered to be 2 weeks after
the fish oil start time reported by the parents in the
questionnaire(s).
Until age 15 months, the incidence of diagnosed sensitization
against food allergens among children who had received regular
fish oil was less than half that among the children who had not
received regular fish oil, and the same was true for confirmed
allergy. After 15 months, the difference in incidence was smaller;
however, firm conclusions cannot be drawn because there were
only a few cases.
A proportional hazards model was constructed to estimate the
protective effect of fish oil in terms of RR. The detailed results are
shown in Table S3 (sensitization) and Table S4 (DBPCFC-allergy). As
stated at the beginning of this section, the primary result of the
modelling was that regular fish oil use significantly reduced the inci-
dence of food sensitization irrespective of family history of allergy,
and also irrespective of sex, mother’s age, number of (young) sib-
lings, presence of pets or other animals in the home, smoking in the
home, parents’ education, mother’s use of fish oil during pregnancy
and consumption of complementary cow milk in the first week
(Table S3, models 15-22, Table S4, models 16-23). The modelling
also showed an insignificant reduction in DBPCFC-confirmed allergy
(RR = 0.57, 95% CI: 0.30-1.12, P = .101). Other possible confound-
ing variables, including caesarean birth, breastfeeding and birth-
weight, were also checked and found to have negligible and
insignificant effects (data not shown). Detailed breakdown of sensiti-
zation and allergy incidence according to age and fish oil use is
shown in Figure S1.
3.6 | Fish oil and food allergy severity
To investigate whether there was a quantitative relationship
between the amount of fish oil given and allergy severity, a linear
regression model was constructed. The results indicated that for chil-
dren who did receive fish oil and became sensitized/allergic to food,
the severity of the condition, measured by the sensitization and
allergy severity index, decreased with the amount of fish oil per
week (Figure 2). There were multiple questions on the frequency of
fish oil supplementation in the questionnaires, and when the
responses were inconsistent, an average was used. Models that
included family allergy history and other confounding variables
yielded similar results (data not shown).
3.7 | Vitamin D supplementation and food
sensitization and allergy
Regular vitamin D from an early age, prior to fish oil supplementa-
tion, was not found to have a significant independent, protective
effect at the P = .05 level, neither on sensitization (RR = 0.86, 95%
CI: 0.55-1.34) nor on food allergy (RR = 0.63, 95% CI: 0.26-1.52,
Tables S3 and S4).
4 | DISCUSSION
4.1 | Findings of this study and other research
The Icelandic EuroPrevall birth cohort gave us a unique opportunity
to prospectively explore the fish oil supplementation status in Ice-
landic children up to 2.5 years of age and relate our results to food
sensitization and food allergy. Our study investigated the effect of
postnatal supplementation with fish oil and the development of
sensitization to food allergens and DBPCFC-confirmed food allergy.
We reported that the incidence of sensitization to food allergens
and DBPCFC-confirmed food allergy up to 2.5 years is halved
when supplementing with fish oil in infancy. We also reported a
dose-dependent relationship of allergy severity and consumption of
fish oil in the same children. Early vitamin D supplementation (rec-
ommended from 2 weeks of age) tended to provide additional pro-
tection, although this finding was not statistically significant in our
model.
Other human studies of postnatal fish oil supplementation have
not shown a similar effect on allergy development. D’Vaz et al,8 in
their study in Australia, did not find significant effects of postnatal
fish oil intervention on the development of allergic diseases in the
first year of life, although it was associated with a favourable
effect on immune function at 6 months. They did find a significant
reduction in eczema prevalence if participants were more than
75% compliant with the supplementation, indicating that some
minimal dose of fish oil is needed. In that study, capsules contain-
ing 250-280 mg of DHA and 100-110 mg of EPA were used,
whereas in our study, each 5-mL dose of fish oil recommended
beginning at age 6 months contained 650 mg of DHA and 350 mg
of EPA as well as 9.2 lg of vitamin D, 138 lg of vitamin A,
4.6 mg of vitamin E and 1.8 g of monounsaturated fatty acids
(MUFA; Table S1). The mothers in the Australian study had
F IGURE 2 Sensitization and allergy severity index according to
the frequency of fish oil administration. There was a significant
relationship (linear regression t test, P = .013)
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restricted fish intake in the last trimester, whereas fish intake was
not restricted in our study. The additional ingredients in the fish
oil may possibly play a role, such as vitamin A, which has been
shown to participate in oral tolerance development,19 and MUFA,
but blood MUFA have recently been associated with reduced
allergy risk at 2-9 years of age.20
Fish oil supplementation during pregnancy and lactation is known
to have an immunomodulatory and allergy-preventive effect on the
offspring.21 In our study, the effect of postnatal fish oil supplementa-
tion on sensitization or confirmed food allergy did not change when
accounting for the mother’s intake of fish oil during pregnancy. Fur-
thermore, the maternal fish oil consumption during pregnancy in our
study did not explain the dose-dependent effect of fish oil intake by
the infants on allergy severity.
Another Australian intervention study used, in a double-blind
manner, 500-mg tuna fish oil capsules containing 184 mg of omega-
3 fatty acids once daily from the age of 6 months vs capsules with
sunflower oil. They did not find a significant difference in allergic
diseases between the intervention group and the controls up to the
age of 3 years apart from reduced atopic cough in the intervention
group.7 Again, the total dose of omega-3 fatty acids in this study
was much lower than that in our study (184 mg vs 1000 mg), which
could explain the different results between these studies. A high
dose of omega-3 fatty acids during pregnancy has been shown to be
more favourable for reducing the development of allergic diseases in
infancy than a lower dose.22
Another important factor was the vitamin D content of the
Icelandic fish oil. A recent meta-analysis and systematic review of
maternal vitamin D status (umbilical blood or serum) and childhood
allergic diseases showed an association between low maternal vita-
min D during pregnancy and an increased risk of childhood
eczema, but not childhood asthma or wheezing.23 A new study by
Hollams et al, also from Australia, investigated atopic development
and vitamin D levels from birth to 10 years of age in a high-risk
birth cohort. They demonstrated with repeated vitamin D mea-
surements that vitamin D level was inversely associated with aller-
gic sensitization, asthma and eczema at 10 years. The authors
noted that a single measurement of vitamin D used in many nega-
tive studies may reflect a short exposure, while repeated measure-
ments reflect ongoing vitamin D exposure and protection.13 The
same research group previously demonstrated that low vitamin D
at 6 years of age leads to an increased risk of developing allergic
sensitization.24
In addition to the dose-dependent explanation given above for
the difference between the two Australian studies7,8 and this study,
exposure to the Australian sun may also play a role, by providing all
the Australian participants with adequate vitamin D.
The timing of fish oil supplementation seems to be important, as
we demonstrated more protection when starting fish oil early. Ani-
mal and human studies have indicated that n-3 PUFA can change
the expression of genes by an epigenetic mechanism and affect the
production of inflammatory mediators and the development of aller-
gic diseases.25,26 There is accumulating evidence that
supplementation with fish oil rich in PUFA and vitamin D has an
effect on the immune system and may, thereby, prevent the devel-
opment of allergic diseases and that the critical time to initiate sup-
plementation is very early in life.10,11,22,27-29
4.2 | Limitations and strengths of this study and
future challenges
This study is part of a larger observational food allergy birth
cohort study, which was not designed to focus on fish oil and
vitamin D. It would have been preferable to obtain more frequent
information on vitamin D and fish oil supplementation. Another
limitation is that we only checked the sensitization of children
who reported some symptoms of allergy, but not the whole
cohort, which means that there may have been some sensitized,
nonsymptomatic children who were not accounted for. Due to a
lack of statistical power, we were unfortunately not able to exam-
ine possible specific protective effects of fish oil on different
types of allergens, as suggested by results from a Dutch experi-
mental study.5
Nevertheless, this was a prospective study based on a large
cohort of 1304 normal-risk children recruited prenatally. Informa-
tion on a large number of possible confounding factors was col-
lected and used in our modelling, and DBPCFC, the gold standard
for the diagnosis of food allergy, was used. Fish oil supplementa-
tion for infants and children is a cultural habit in Iceland. At the
same time, a considerable number of parents do not follow the
official recommendations, providing a unique opportunity to com-
pare two large groups of children, namely, those who receive and
do not receive fish oil.
Our results apply to Icelandic children, and it would be inter-
esting to carry out a similar analysis based on the EuroPrevall
cohort for other European countries, both within countries and
between countries. Further studies are needed to determine which
of the ingredients in the cod fish oil explain the protective find-
ings of our study.
5 | CONCLUSIONS
Our study showed that fish oil supplementation in children starting
before or at 6 months may decrease food sensitization and food
allergy in young children by more than half, with potential large pub-
lic health implications. The study also indicated that regular fish oil
may decrease food allergy severity.
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